TrialAdvances in therapy2016

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.

Hans-Peter Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.